Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
CARLSBAD, Calif., Feb. 28, 2017 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in three upcoming investor conferences.
- March 7th, 2017 at 8:00 a.m. ET, SeaSpine's management is scheduled to present at the Cowen & Company 37th Annual Healthcare Conference in Boston, MA
- March 14th, 2017 at 9:30 a.m. PT, SeaSpine's management is scheduled to present at the Canaccord Genuity 2017 Musculoskeletal Conference San Diego, CA
- March 21st, 2017 at 10:20 a.m. ET, SeaSpine's management is scheduled to present at the Oppenheimer 27th Annual Healthcare Conference in New York City, NY
Interested parties can access the live audio webcast at http://www.seaspine.com.
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development helps SeaSpine to offer its surgeon customers a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.
Investor Relations Contact Lynn Pieper Lewis (415) 937-5402 [email protected]
